Disc Medicine Stock Target Price and Analyst Consensus
| IRON Stock | 78.30 1.42 1.78% |
The current analyst and expert consensus on Disc Medicine is Strong Buy, with 8 strong buy opinions. The current projected Disc Medicine target price consensus is 122.08 with 11 analyst opinions. Check out Macroaxis Advice on Disc Medicine to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.The most common way Disc Medicine analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Disc Medicine executives and customers to further validate their buy or sell advice. Disc Medicine buy-or-sell recommendation module provides average expert sentiment on the projected Disc Medicine target price to derive its highest and lowest estimates based on projected price volatility of 2.8654.
Lowest Forecast 111.1 | Highest Forecast 135.51 | Target Price 122.08 |
It's important to approach Disc Medicine's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Disc Medicine Target Price Consensus
Disc target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Disc Medicine's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 11 | Strong Buy |
Most Disc analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Disc stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Disc Medicine, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationDisc Medicine Target Price Projection
Disc Medicine's current and average target prices are 78.30 and 122.08, respectively. The current price of Disc Medicine is the price at which Disc Medicine is currently trading. On the other hand, Disc Medicine's target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Disc Medicine Market Quote on 9th of February 2026
Target Price
Analyst Consensus On Disc Medicine Target Price
Disc Medicine Analyst Ratings
Disc Medicine's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Disc Medicine stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Disc Medicine's financials, market performance, and future outlook by experienced professionals. Disc Medicine's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Disc Medicine price targets
Disc Medicine's stock target price is an estimate of its future price, usually made by analysts. Using Disc Medicine's target price to determine if it is a suitable investment can be done through the following steps:- Look at Disc Medicine's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Disc Medicine's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Disc Medicine Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Disc Medicine is a key component of Disc Medicine valuation and have some predictive power on the future returns of a Disc Medicine.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | SRI Sustainable Growth Invested over 90 shares | |
 | ESG Investing Sold few shares | |
 | Corona Opportunity Invested over 90 shares | |
Check out Macroaxis Advice on Disc Medicine to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.